Correlation Between Acrivon Therapeutics, and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Ikena Oncology, you can compare the effects of market volatilities on Acrivon Therapeutics, and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Ikena Oncology.
Diversification Opportunities for Acrivon Therapeutics, and Ikena Oncology
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Acrivon and Ikena is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Ikena Oncology go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Ikena Oncology
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to under-perform the Ikena Oncology. In addition to that, Acrivon Therapeutics, is 3.39 times more volatile than Ikena Oncology. It trades about -0.07 of its total potential returns per unit of risk. Ikena Oncology is currently generating about -0.03 per unit of volatility. If you would invest 171.00 in Ikena Oncology on August 30, 2024 and sell it today you would lose (2.00) from holding Ikena Oncology or give up 1.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Ikena Oncology
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Ikena Oncology |
Acrivon Therapeutics, and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Ikena Oncology
The main advantage of trading using opposite Acrivon Therapeutics, and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Acrivon Therapeutics, vs. Ikena Oncology | Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. RenovoRx |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |